TTL and neoplasm: As shown in Figure 6a, oncoVV-TTL and oncoVV-GM-CSF did not significantly suppress HCT116 tumor growth, as compared to PBS control, while oncoVV-AVL significantly inhibited the growth of HCT116 tumors in mice.